Impact Biomedical Inc. (IBO)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Keeps a healthy share of every dollar it sells.
- Revenue
- $35K
- Net income
- $789K
- Net margin
- 2254.3%
Little or no net debt.
- Total debt
- $0
- Cash
- $10K
- Debt / equity
- 0.00
Owes more within a year than it holds to pay it.
- Current assets
- $320K
- Current liabilities
- $2.0M
- Current ratio
- 0.16
Consumes cash and must keep raising it.
- Operating cash flow
- -$508K
- Free cash flow
- -$508K
- FCF margin
- -1451.4%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 8.5M
- Share growth (1y)
- 784.8%
- Cash runway
- 0 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
IBO Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 3.00 K | 7.00 K | 7.00 K | 18.00 K | 7.00 K | 0.00 |
| Revenue Growth (YoY) | -57.14 % | — | — | — | — | — |
| Cost of Revenue | 1.00 K | 0.00 | 422.00 K | 1.00 K | 1.00 K | 0.00 |
| Gross Profit | 2.00 K | 7.00 K | -415.00 K | 17.00 K | 6.00 K | 0.00 |
| SG&A Expense | 277.00 K | 1.90 M | 275.00 K | 516.00 K | 676.00 K | 509.00 K |
| R&D Expense | 76.00 K | 46.00 K | 110.00 K | 52.00 K | 75.00 K | 103.00 K |
| Operating Expenses | 704.00 K | 2.30 M | 743.00 K | 965.00 K | 1.16 M | 1.01 M |
| Operating Income | -702.00 K | -2.29 M | -1.16 M | -948.00 K | -1.15 M | -1.01 M |
| Pretax Income | -700.00 K | -2.28 M | 2.65 M | -1.48 M | -14.35 M | -1.28 M |
| Tax Provision | 0.00 | 0.00 | -2.58 M | 0.00 | 0.00 | 0.00 |
| Net Income | -699.00 K | -2.29 M | 5.25 M | -1.47 M | -14.35 M | -1.27 M |
| EPS (Basic) | -0.08 | -0.27 | 0.63 | -1.51 | -14.89 | -1.26 |
| EPS (Diluted) | -0.08 | -0.27 | 0.63 | -1.51 | -14.89 | -1.26 |
| Shares Outstanding | 8.54 M | 8.54 M | 2.50 M | 965.56 K | 965.56 K | 955.84 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.